Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $5.6M

Reported trades

Filed Stock Type Shares Price Value Since
Mar 11SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 17,98130,827 held (−37%) $45.58 $820K +75.0%
Mar 11SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 18,74112,086 held (−61%) $46.24 $867K +72.5%
Feb 11SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 9,11420,817 held (−30%) $42.85 $391K +86.2%
Feb 11SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 8,73112,086 held (−42%) $43.72 $382K +82.5%
Jan 9SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 12,00019,086 held (−39%) $41.89 $503K +90.5%
Dec 10SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 42,84131,086 held (−58%) $41.49 $1.8M +92.3%
Nov 14SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 19,90031,086 held (−39%) $40.94 $815K +94.9%
Oct 30SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 10031,086 held (−0%) $41.00 $4K +94.6%
  • Sell

    CFO Mark Ragosa sold $820K of KNSA at $45.58 — cuts the stake by 37%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Mark Ragosa sold $867K of KNSA at $46.24 — cuts the stake by 61%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Mark Ragosa sold $391K of KNSA at $42.85 — cuts the stake by 30%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Mark Ragosa sold $382K of KNSA at $43.72 — cuts the stake by 42%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Mark Ragosa sold $503K of KNSA at $41.89 — cuts the stake by 39%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Mark Ragosa sold $1.8M of KNSA at $41.49 — cuts the stake by 58%; pre-scheduled 10b5-1 plan sale.